Bayer Consumer Health names Dr. Ricardo Salazar Hernández Chief Medical Officer

“From product safety and effectiveness, to helping create entirely new solutions based on medical insights, credible science has always been at the heart of science-led self-care at Bayer,” said Abbie Lennox, Chief Regulatory, Medical, Safety and product Compliance officer at Consumer Health. “The extensive public and private sector medical experience Ricardo brings to bear will help us continue to shape the transformation of everyday health for consumers.”

Dr. Salazar was born and educated in Mexico and he has more than 15 years of experience in the pharmaceutical industry. He joins Bayer from Sanofi where he most recently was global medical Head for Consumer Health Care (CHC) & Evidence generation head. He is a trained MD with a master’s degree in health business administration. He also completed post graduate studies in pharmaceutical medicine at the University of Cardiff, UK. Prior to his current role, he has held various roles of increasing responsibility in Mexico, Brazil, France and Panama in medical affairs and business development.

“I am really happy to join and be part of the Bayer team, and am looking forward to helping continue to build a stronger, high-performing medical organization that is able to deliver new medical insights, scientific claims and new data generation,” said Dr. Salazar. “We will work together to help consumers and healthcare professionals to make informed decisions about our exciting product portfolio.”

Earlier in his career, Dr. Salzar worked as an Advisor at the Ministry of Health in Mexico, an Associate Professor at ITESM CDM Medical School in Mexico and in private medical practice at Hospital Médica Sur in Mexico City. Ricardo and his wife Gaby have two children, Mateo and Mikel. The Salazar family will relocate from Panama to Whippany, New Jersey.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.